| 2021 | Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061
| GASTRIC CANCER |
| 2017 | HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib.
| MOLECULAR CANCER THERAPEUTICS |
| 2014 | High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
| 1997 | High Level of Urokinase-Type Plasminogen Activator Is a New Prognostic Marker in Patients with Gastric Carcinoma | CANCER |
| 2012 | High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection
| ONCOLOGY LETTERS |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 1996 | Human Lung Cancer에서 면역세포화학적 방법을 이용한 Tumor Angiogenesis에 관한 연구
| TUBERCULOSIS AND RESPIRATORY DISEASES(결핵 및 호흡기질환) |
| 2022 | Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer | EUROPEAN JOURNAL OF CANCER |
| 2021 | Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
| 2012 | Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
| BMC GENOMICS |
| 2012 | Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2011 | Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells | BREAST CANCER RESEARCH AND TREATMENT |
| 2010 | Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2007 | Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer | GENOMICS |
| 2010 | Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray | JOURNAL OF SURGICAL ONCOLOGY |
| 2009 | Identification of significant regional genetic variations using continuous CNV values in aCGH data | GENOMICS |
| 2019 | Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
| Cancer Research and Treatment |
| 2008 | Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions
| BMC BIOINFORMATICS |
| 2009 | In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer | GENOMICS |
| 2015 | Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
| CANCER RESEARCH AND TREATMENT |
| 2013 | Increased Alternative Lengthening of Telomere Phenotypes of Telomerase-negative Immortal Cells upon Trichostatin – A Treatment | ANTICANCER RESEARCH |
| 2009 | Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2011 | Inflammatory and tumor stimulating responses after laparoscopic sigmoidectomy
| YONSEI MEDICAL JOURNAL |
| 2014 | Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer | JOURNAL OF PSYCHOSOMATIC RESEARCH |
| 2003 | Infusional Fluorouracil, Etoposide, and Cisplatin (FEP) in Advanced and Relapsed Gastric Cancer | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2019 | Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer | GASTRIC CANCER |
| 2008 | Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene
| CANCER RESEARCH |
| 2021 | Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer | CELLULAR ONCOLOGY |
| 2007 | Integrated in silico and biological validation of the blocking effect of C(o)t-1 DNA on microarray-CGH | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2006 | Intermediate Dose 5-Fluorouracil-Induced Encephalopathy
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2001 | Intravenous 5-Fluorouracil Versus Oral Doxifluridine as Preoperative Concurrent Chemoradiation for Locally Advanced Rectal Cancer: Prospective Randomized Trials
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2007 | Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG) | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2010 | Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine? | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2007 | Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment | JOURNAL OF CLINICAL ONCOLOGY |
| 2004 | Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas | LEUKEMIA & LYMPHOMA |
| 2015 | LAMC2 enhances the metastatic potential of lung adenocarcinoma | CELL DEATH AND DIFFERENTIATION |
| 2019 | Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients
| Cancer Research and Treatment |
| 2016 | Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2014 | Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study | JOURNAL OF CLINICAL ONCOLOGY |
| 2001 | Leptomeningeal Carcinomatosis in Solid Tumors ; Clinical Manifestation and Treatment
| Journal of the Korean Cancer Association (대한암학회지) |
| 2006 | Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports
| CANCER RESEARCH AND TREATMENT |
| 2021 | MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma
| FUTURE ONCOLOGY |
| 2019 | Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
| FUTURE ONCOLOGY |
| 2022 | Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A | ESMO OPEN |
| 2018 | Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial | ANNALS OF SURGICAL ONCOLOGY |
| 2013 | Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer
| JOURNAL OF RADIATION RESEARCH |
| 1998 | Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2019 | Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer | ONCOLOGIST |
| 2018 | MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. | JOURNAL OF SURGICAL ONCOLOGY |
| 2012 | Methylation status of lamin A/C in gastric cancer cell lines | HEPATO-GASTROENTEROLOGY |
| 2011 | MMP-2 as a putative biomarker for carcinomatosis in gastric cancer | HEPATO-GASTROENTEROLOGY |
| 2004 | MN/CA9 촉진자를 가진 replication-competent 아데노바이러스를 이용한 신세포암에 대한 종양 특이적 유전자요법
| KOREAN JOURNAL OF UROLOGY |
| 2008 | Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer | CANCER LETTERS |
| 1999 | Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer | International Journal of Molecular Medicine |
| 2017 | Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines | BIOCHEMICAL PHARMACOLOGY |
| 2007 | Molecular basis of the differences between normal and tumor tissues of gastric cancer | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE |
| 2021 | Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses | HEPATOLOGY |
| 2021 | Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma
| ANNALS OF ONCOLOGY |
| 2023 | Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy
| YONSEI MEDICAL JOURNAL |
| 2001 | Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer | CANCER LETTERS |
